TY - CHAP
T1 - Gangliosides in Nerve Cell Specification
AU - Itokazu, Yutaka
AU - Wang, Jing
AU - Yu, Robert K.
N1 - Funding Information:
This work was supported by a VA Merit Review Award (1 I01BX001388 to RKY), NIH grants (RO1 NS100839, NS26994, and NS11853 to RKY), and Mizutani Foundation for Glycoscience (150026 to YI). The authors declare no conflicts of interest.
Publisher Copyright:
© 2017
PY - 2018/1/1
Y1 - 2018/1/1
N2 - The central nervous system is generated from progenitor cells that are recognized as neural stem cells (NSCs). NSCs are defined as undifferentiated neural cells that are characterized by the capacity for self-renewal and multipotency. Throughout neural development, NSCs undergo proliferation, migration, and cellular differentiation, and dynamic changes are observed in the composition of carbohydrate-rich molecules, including gangliosides. Gangliosides are sialic acid-containing glycosphingolipids with essential and multifaceted functions in brain development and NSC maintenance, which reflects the complexity of brain development. Our group has pioneered research on the importance of gangliosides for growth factor receptor signaling and epigenetic regulation of ganglioside biosynthesis in NSCs. We found that GD3 is the predominant ganglioside species in NSCs (>80%) and modulates NSC proliferation by interacting with epidermal growth factor receptor signaling. In postnatal brain, GD3 is required for long-term maintenance of NSCs. Deficiency in GD3 leads to developmental and behavioral deficits, such as depression. The synthesis of GD3 is switched to the synthesis of complex, brain-type gangliosides, namely, GM1, GD1a, GD1b, and GT1b, resulting in terminal differentiation and loss of “stemness” of NSCs. In this process, GM1 is augmented by a novel GM1-modulated epigenetic gene regulation mechanism of glycosyltransferases at a later differentiation stage. Consequently, our research suggests that stage-specific gangliosides play specific roles in maintaining NSC activities and in cell fate determination.
AB - The central nervous system is generated from progenitor cells that are recognized as neural stem cells (NSCs). NSCs are defined as undifferentiated neural cells that are characterized by the capacity for self-renewal and multipotency. Throughout neural development, NSCs undergo proliferation, migration, and cellular differentiation, and dynamic changes are observed in the composition of carbohydrate-rich molecules, including gangliosides. Gangliosides are sialic acid-containing glycosphingolipids with essential and multifaceted functions in brain development and NSC maintenance, which reflects the complexity of brain development. Our group has pioneered research on the importance of gangliosides for growth factor receptor signaling and epigenetic regulation of ganglioside biosynthesis in NSCs. We found that GD3 is the predominant ganglioside species in NSCs (>80%) and modulates NSC proliferation by interacting with epidermal growth factor receptor signaling. In postnatal brain, GD3 is required for long-term maintenance of NSCs. Deficiency in GD3 leads to developmental and behavioral deficits, such as depression. The synthesis of GD3 is switched to the synthesis of complex, brain-type gangliosides, namely, GM1, GD1a, GD1b, and GT1b, resulting in terminal differentiation and loss of “stemness” of NSCs. In this process, GM1 is augmented by a novel GM1-modulated epigenetic gene regulation mechanism of glycosyltransferases at a later differentiation stage. Consequently, our research suggests that stage-specific gangliosides play specific roles in maintaining NSC activities and in cell fate determination.
KW - brain development
KW - epigenetic regulation
KW - epithelial growth factor receptor
KW - growth factor
KW - growth factor receptor
KW - lipid raft
KW - neural cell fate determination
KW - neural progenitor cell
KW - neural stem cell
KW - neurogenesis
UR - http://www.scopus.com/inward/record.url?scp=85040557797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040557797&partnerID=8YFLogxK
U2 - 10.1016/bs.pmbts.2017.12.008
DO - 10.1016/bs.pmbts.2017.12.008
M3 - Chapter
C2 - 29747816
AN - SCOPUS:85040557797
SN - 9780128123416
T3 - Progress in Molecular Biology and Translational Science
SP - 241
EP - 263
BT - Progress in Molecular Biology and Translational Science
A2 - Schnaar, Ronald L.
A2 - Lopez, Pablo H.H.
PB - Elsevier B.V.
ER -